CLIA Application for Certification


Provider Relief Fund: Medicaid  and CHIP Provider Distribution Fact Sheet (HHS Extends Application Deadline for Medicare General Distribution Funding and Medicaid-Only Funding Until August 28 )


Guidelines for Opening Up America Again


State Attorney General Contact List


Upcoming Webinars

The Compliance Team: Leading the Way in the Time of Covid-19; 08/13/2020

How the DME Supplier Can Work with an Accountable Care Organization (“ACO”); 08/18/2020, 2:30 ET

Innovative Teaching and Learning Models in the COVID-19 Era: Part I; 08/26/2020, 3PM ET


Past Webinars

Click here for past webinars



Coronavirus FDA Testing Basics


Alternate Site (Home Infusion/Specialty) Pharmacy Resources

Home Infusion Press Coverage During COVID-19

NASP COVID-19 Resources

NHIA COVID-19 Resource Center

NICA COVID-19 Guidance and Resource Toolkit:

IgNS COVID-19 Resource Guide and FAQ


Clinical Resources

MHA is pleased to provide MHA members with insights from IPD Analytics.  They are continuing to monitor the impact of COVID-19 to the pharmaceutical industry with respect to clinical trials aimed at vaccine development and investigational and currently available treatments.

IPD Analytics COVID Executive Summary 6.20.2020

IPD Analytics Treatments 6.30.2020

IPD Analytics RxBrief_COVID-19 Vaccines Update_05 29 2020_2

American College of Cardiology Guidance on Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19

ASHP Coronavirus Page

CDC Coronavirus Page


Center for Infectious Disease Research and Policy, University of Minnesota COVID-19

CMS Coronavirus page

DEA Diversion Control Division Coronavirus Resources

FDA Coronavirus Treatment Acceleration Program (CTAP)


Health and Human Services

Infectious Disease Society of American 

Johns Hopkins COVID-19

LANCET Coronavirus

Pharmacist Letter COVID-19 Resource Hub (articles free for everyone; CE available for those with a Pharmacist’s Letter subscription)

Society of Critical Care Medicine 

Society of Infectious Disease Pharmacists COVID 19 Resource

University of Nebraska Medical Center COVID-19

University of Washington COVID-19 Center, including sample policies and procedures

Wolters Kluwer Up-To-Date Clinical Effectiveness COVID-19 Resources (Available to all)

World Health Organization (WHO)



HHS Advisory Opinion 20-02 on the Public Readiness and Emergency Preparedness Act and the Secretary’s Declaration Under the Act 05.19.2020

Nursing Home Reopening Recommendations for State and Local Officials 5-17-2020

Pharmacy Testing for COVID-19


Data and Projections 

Institute for Health Metric and Evaluation (HME) Coronavirus US Projections

John Hopkins Coronavirus Dashboard

CDC Cases in the US

National Vital Statistics System Coronavirus Related Deaths 


Drug Shortage Information

ASHP Drug Shortages

FDA Drug Shortages


General Trade Associations


Healthcare Information and Management Systems Society, Inc. (HIMSS)

Health Industry Distributors Association COVID-19 Resource Center 

NCPA Coronavirus Information


Employee Resources

Healthy Telework Habits April 2020

Working Remotely During COVID-19 Center for Workplace Mental Health Guide

Families First Coronavirus Response Act and Emergency Sick Leave April 2020

Employee Rights Under the Families First Coronavirus Response Act



HIPAA Journal

Urgent Notices

FBI Sees Rise in Fraud Schemes Related to the Coronavirus (COVID-19) Pandemic
Scammers are leveraging the COVID-19 pandemic to steal your money, your personal information, or both. The FBI advises you to be on the lookout for the following: Fake CDC Emails, Phishing Emails, Counterfeit Treatments or Equipment. Visit the FBI site for more information.

HHS Office for Civil Rights in Action
It has come to OCR’s attention that an individual posing as an OCR Investigator has contacted HIPAA covered entities in an attempt to obtain protected health information (PHI). The individual identifies themselves on the telephone as an OCR investigator but does not provide an OCR complaint transaction number or any other verifiable information relating to an OCR investigation. Visit the NIH site for more information.


Long Term Care Facilities

AHCA/NCAL Coronavirus Resource Page

U.S. Senators Casey and Wyden Call on CMS/CDC to Make Covid-19 Nursing Facilities Public

FCC Report and Order Establishing COVID-19 Telehealth Program (WC Docket No. 20-89) (Page 13: “Eligible Health Care Providers. Consistent with the 1996 Act and the CARES Act, we limit the program to nonprofit and public eligible health care providers that fall within the categories of health care providers…”)

American Hospital Association’s Petition for Reconsideration (WC Docket No. 20-89) – April 9, 2020

Additional Information FCC – COVID-19 Telehealth Program

Additional Filings Under COVID-19 Telehealth Program (WC Docket No. 20-89)

Visitation Considerations for Nursing Home Residents


Long Term Care Pharmacy Resources

ASCP Coronavirus Resources

AMDA Update on COVID-19

CDC Preparing for COVID-19: Long-term Care Facilities, Nursing Homes, including preparedness checklist 

CMS Survey Information: CMS Coronavirus page

Senior Care Pharmacy Coalition COVID-19 Resources


MHA Response to COVID-19

MHA President Diane Koontz’s Official Comments to CMS March 19, 2020

MHA President Diane Koontz’s Follow Up Comments to CMS March 24, 2020


Small Business

Chadler Solutions Webinar: COVID-19 Response Act-Paid Leave & State Programs

COVID-19 Guidance for Small Business

Department of Labor Coronavirus Resources

Disaster Loan Assistance

NSBA’s Advocacy Efforts 

US Dept of Labor, Families First Coronavirus Response Act: FAQ


State Resources

National Governors Association Coronavirus Updates

NGA COVID-19 Telehealth Memo 

NGA Mem on Older Adults and Disabled 4-3-20

State Health Departments


COVID-19 Workforce and Labor Issues | March 31

COVID-19: Education, Child Care and Nutrition | April 3


U.S. Congress

U.S. House of Representatives Live Feed 

U.S. Senate Live Feed


Not finding what you need? Email and let us know!